Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial
- Resource Type
- Article
- Authors
- Freeman, Sylvie D.; Thomas, Abin; Thomas, Ian; Hills, Robert K.; Vyas, Paresh; Gilkes, Amanda; Metzner, Marlen; Jakobsen, Niels Asger; Kennedy, Alison; Moore, Rachel; Almuina, Nuria Marquez; Burns, Sarah; King, Sophie; Andrew, Georgia; Gallagher, Kathleen M. E.; Sellar, Rob S.; Cahalin, Paul; Weber, Duruta; Dennis, Mike; Mehta, Priyanka; Knapper, Steven; Russell, Nigel H.
- Source
- In Blood 16 November 2023 142(20):1697-1707
- Subject
- CME article
Clinical Trials and Observations
Free Research Articles
Myeloid Neoplasia
- Language
- ISSN
- 0006-4971